Complex traits can share a substantial proportion of their polygenic heritability.
Introduction
Most complex traits follow a polygenic model of inheritance, whereby thousands of common genetic variants contribute to phenotypic variance. Furthermore, genetic variance is not spread evenly throughout the genome but rather tends to concentrate in specific regions [1] [2] [3] . While shared polygenic heritability between pairs of complex traits has been shown at a genome-wide level 4 , there are currently no methods to evaluate regional polygenic covariance between two traits using summary association statistics. Existing methods for regional covariance either use individual-level data 5, 6 or test for co-localisation of single variant associations without considering polygenic inheritance [7] [8] [9] [10] . Nonetheless, the observation that a majority of polygenic heritability lies in variants associated below genome-wide significance coupled with the concentration of such associations at specific loci dictates the need for a method that can estimate polygenic covariance within small (~1 Mb) regions. As each genetic region includes a different set of genes, genome-wide correlations will miss heterogeneity in the contribution of individual genes to shared heritability. Also, current co-localisation methods have been designed to identify linked eQTLs 7, 11 , which typically harbour very strong associations unlike most other complex traits.
We now propose a novel method (WML-RPC) to estimate the regional polygenic covariance between two traits, retaining all variants in a given region irrespective of linkage disequilibrium (LD) and using summary association statistics. Our method adopts a weighted maximum likelihood approach to estimate the regional polygenic variance of each trait and their polygenic covariance. It assumes random polygenic effects, or in other words, that multiple genetic variants are associated with a trait in each region. Our framework builds on previous work 1, 12 and has the distinct advantage of being robust to misspecification of either LD or genetic effect sizes. Unlike other approaches, our method makes no assumption about the causal relationship of one trait over the other but rather is intended to test whether a single polygenic effect affects two traits concurrently at a given locus. In addition, as WML-RPC provides estimates for the strength of the polygenic covariance, it can be used to test for the presence of covariance or alternatively for deviation from a set level of covariance. We illustrate the usefulness of our method by applying it to three questions related to cardio-metabolic traits, bringing novel insights into the inverse association of HDL cholesterol with coronary artery disease (CAD), identifying a region on chromosome 8p23.1 with multiple strong signals of pairwise genetic covariance, and exploring the role of PPARγ activators in the prevention of CAD.
Results

Simulations with 1000 Genomes Project Haplotypes
We simulated two traits using phased 1000 Genomes (1000G) Project 13 haplotypes. The simulated regions comprised 700 SNPs, corresponding to a physical distance of ~1Mb, and summary association statistics were generated in two distinct populations of 100,000 participants each. Assuming realistic levels of genetic association, there was no type I error inflation when either or both traits were truly genetically associated in the absence of any genetic covariance.
Power to detect genetic covariance was dependent on genetic effect sizes and strength of true underlying genetic covariance ( Figure 1 ). We evaluated the influence of correlated error terms as could occur if summary association statistics were derived from overlapping sets of participants.
With 25% of participants overlapping and the non-genetic correlation between traits set at ߩ ൌ 0 . 2
, the impact on both type I error rate and power was minimal (Figures S1 and S2) . We also tested a more extreme scenario that assumed a complete overlap in participants (i.e.
correlation of non-genetic error terms of 0.2). Again, minimal type I error inflation was observed under the null hypothesis of no covariance (Figures S1 and S2) . Finally, we sought to benchmark our method against two recently described co-localisation methods 8, 10 . Both methods assess the possibility that a single causal variant underlies a genetic association with two traits. As expected given their model assumptions, neither method performed well in the presence of polygenic inheritance, with both showing inflated type I error rates and decreased power as compared to WML-RPC ( Figure S3 ).
Insights into the relationship between HDL cholesterol and coronary artery disease
To illustrate how regional polygenic covariance can provide novel epidemiological insights, we first explored the genetic relationship between HDL cholesterol (HDLc) and coronary artery disease (CAD) using summary association statistics from large genetic meta- We then tested this set of traits for polygenic covariance with diabetes and CAD ( Table 2 ).
Significant and positive polygenic covariance was observed between diabetes and triglycerides, triglycerides and CAD, and LDLc and CAD. Significant negative polygenic variance was observed between diabetes and BMI. However, polygenic covariance was not significant between diabetes and LDLc, or diabetes and CAD. Polygenic covariance between LDLc and CAD is of particular interest since pioglitazone has recently been shown to reduce LDL particle number and size 41, 42 . This observation and the polygenic covariance with triglycerides support the hypothesis that the protective effect of pioglitazone (and perhaps other thiazolidinediones) on CAD risk is the consequence of its beneficial effect on atherogenic lipoproteins.
Discussion
We herein propose a novel method to estimate regional polygenic covariance between two traits. Our method is distinct from other co-localisation tests as it is based on a polygenic model of inheritance and it makes no assumptions about the causal relationship between traits.
This approach is particularly attractive when studying complex traits with strong polygenic inheritance, where any single genetic association is unlikely to fully capture a large proportion of genetic effects. Our method has several other advantages, including the ability to adjust for LD, the possibility to test specific hypotheses regarding polygenic covariance, and the use of summary association statistics as inputs. WML-RPC has wide ranging applications, as we have illustrated. It can help discover biological pathways explaining epidemiological associations such as for HDLc and CAD, identify regions with complex patterns of polygenic covariance, or help gain insights into the role of single genes or drug targets.
Our examples make a compelling argument that shared heritability is highly dependent on regional genetic effects. Even for established relationships such as the one between BMI and triglycerides, some regions could be found where increased BMI was linked to decreased triglycerides. Unless a locus has a direct effect on a risk factor (e.g. the APOB or LDLR loci on LDLc), it thus cannot be assumed covariance implies a causal effect of the risk factor on outcome. In conclusion, we present a novel method to estimate regional polygenic covariance using summary association statistics. WML-RPC can estimate polygenic covariance within relatively small genetic regions, enabling a more detailed characterization of genetic covariance than genome-wide genetic correlations. Our method can be used to identify pathways shared between two traits, pinpoint regions of interest, or test specific hypotheses for a given gene. Our examples illustrate the heterogeneity in pairwise genetic covariance across loci. They support the notion that genetic effects are specific to each region and that unless a locus directly affects a risk factor, caution must be exercised when making causal inferences.
Methods
Estimation of regional genetic variance and covariance
We recently described a simple procedure to estimate regional genetic variance using summary association statistics, adjusting for linkage disequilibrium (LD) 12 . We now propose to adapt this procedure to estimate polygenic covariance between a pair of traits using a weighted maximum likelihood (WML) approach. Suppose the genotype matrix is fixed while the true genetic effect is a random vector when the sample size is sufficiently large.
Since the true genetic effects are given by a random vector 
where the log-likelihood of each observed is the error term covariance and can be assumed to be zero.
The weighted likelihood function can be adapted using genetic variance estimates from the previous weighted likelihood:
The maximum likelihood estimates of no bias in regional polygenic variance under the null hypothesis of no genetic association, which we checked using simulations ( Figure S4 ).
Simulations using 1000 Genomes Project data and study of cardio-metabolic traits
We tested our method using summary association statistics from large genetic meta- 
